Astorg plans for Oxoid Remel to acquire Solabia’s microbiology diagnostics division
Tuesday, October 20, 2026 · first reported by PE Hub
Astorg plans for portfolio company Oxoid Remel to acquire Solabia's microbiology diagnostics division, which includes Biokar Diagnostics and focuses on microbiological culture media.
- Firm
- Astorg
- Also named
- Oxoid Remel, Solabia, Biokar Diagnostics
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- KKR inks $2.9bn sale of railcar lessor Infinity Transportation to AresPE Hub +5
- EQT Infrastructure to acquire Australian waste management firm Cleanaway at $6.5bn valuationPE Hub +4
- 5 Firms Steer $3.4B Silgan, Trivium Packaging DealLaw360
- Arlington Capital Partners completes take-private of UK photonics firm Gooch & HousegoPE Hub
- Platinum Equity to acquire majority stake in Italian equipment maker TrimePE Hub
- Rockpool Investments backs buyout of Industrial Door Systems for buy-and-buildPE Hub